β¨ Health and Trade Notices
NEW ZEALAND GAZETTE, No. 121 β 22 DECEMBER 2016
All persons importing hot water bottles for supply in trade after the date of this notice may need to provide the New Zealand Customs Service with acceptable documentation demonstrating that the import of those hot water bottles is not prohibited by this notice.
Commerce Commission requirements
Section 31(5) of the Act prohibits the supply, or offer to supply, or advertisement to supply goods in respect of which there is in force an unsafe goods notice. All persons supplying, or offering to supply, or advertising to supply hot water bottles to which this notice applies must comply with the requirements of the Commerce Commission.
2016-go7272
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Aspirin 300mg
Active Ingredient: Aspirin 300mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Daund, India
Product: Linezolid APOTEX
Active Ingredient: Linezolid 600mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Research Private Limited, Bangalore, India
Product: Senna Laxative Tablets
Active Ingredient: Calcium sennosides 39.375mg equivalent to sennosides 7.5mg
Dosage Form: Tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Sigma Laboratories Limited, Mapusa, India
Dated this 19th day of December 2016.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go7276
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: ELOCTATE
Active Ingredient: Efmoroctocog alfa 250IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Biogen NZ Biopharma Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Product: ELOCTATE
Active Ingredient: Efmoroctocog alfa 500IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Biogen NZ Biopharma Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
66
Next Page →
β¨ LLM interpretation of page content
π
Unsafe Goods (Hot Water Bottles) Permanent Prohibition Notice 2016
(continued from previous page)
π Trade, Customs & Industry14 December 2016
Unsafe Goods, Prohibition, Hot Water Bottles, Fair Trading Act 1986, BS1970:2012, ISO 17025
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare19 December 2016
Medicines, Distribution, Aspirin, Linezolid, Senna Laxative, REX Medical Limited, Cipla Limited, Apotex NZ Limited, AFT Pharmaceuticals Limited
- CHRIS JAMES, Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare19 December 2016
Medicines, Distribution, ELOCTATE, Efmoroctocog alfa, Biogen NZ Biopharma Limited, Vetter Pharma-Fertigung GmbH & Co KG
- CHRIS JAMES, Group Manager, Medsafe, Ministry of Health
NZ Gazette 2016, No 121